SC 13G/A: Roivant Sciences Ltd.
Ticker: ROIV · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 1635088
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Roivant Sciences Ltd..
Risk Assessment
Risk Level: low
Filing Stats: 882 words · 4 min read · ~3 pages · Grade level 9.5 · Accepted 2024-02-13 17:26:49
Key Financial Figures
- $0.0000000341740141 — f Class of Securities: Common Shares, $0.0000000341740141 per share. (e) CUSIP Number: G76279 10
Filing Documents
- eps11173.htm (SC 13G/A) — 27KB
- 0001171520-24-000124.txt ( ) — 28KB
(a)Name of Issuer
ITEM 1. (a)Name of Issuer: Roivant Sciences Ltd. (b) Address of Issuer’s Principal Executive Offices: 7th Floor, 50 Broadway, London SW1H 0DB, United Kingdom.
(a)Name of Person Filing
ITEM 2. (a)Name of Person Filing: This Amendment to Schedule 13G (the “ Amendment ”) is being filed by Vivek Ramaswamy (the “ Reporting Person ”). (b) Address of Principal Business Office, or if None, Residence: The principal office and business address of the Reporting Person is c/o Roivant Sciences Ltd., 7th Floor, 50 Broadway, London SW1H 0DB, United Kingdom. (c) Citizenship or Place of Organization: See row 4 of the cover page to this Amendment. (d) Title of Class of Securities: Common Shares, $0.0000000341740141 per share. (e) CUSIP Number: G76279 101 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: Not Applicable.
OWNERSHIP
ITEM 4. OWNERSHIP. All calculations of percentage ownership herein are based on an aggregate of 835,371,101 common shares issued and outstanding as of February 9 th 2024, based on (i) 805,846,006 common shares issued and outstanding as of February 9 th 2024 as disclosed by the Issuer in its Form 10-Q for the quarterly period ended December 30, 2023, as filed with the Securities and Exchange Commission on February 13 2024 and (ii) 29,525,095 common shares underlying Options held by Mr. Ramaswamy that are subject to vesting and settlement within 60 days of December 31, 2023 and are deemed outstanding pursuant to SEC Rule 13-3(d)(1)(i). The information set forth in Item 2 above is incorporated by reference for the Reporting Person. (a) Amount beneficially owned: 81,454,521 common shares, consisting of (i) 51,929,426 RSAs covering common shares and (ii) 29,525,095 common shares underlying Options. (b) Percent of class: 9.75% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 81,454,521 common shares, consisting of (i) 51,929,426 RSAs covering common shares and (ii) 29,525,095 common shares underlying Options. (ii) Shared power to vote or to direct the vote: N/A (iii) Sole power to dispose or to direct the disposition of: 81,454,521 common shares, consisting of (i) 51,929,426 RSAs covering common shares and (ii) 29,525,095 common shares underlying Options. (iv) Shared power to dispose or to direct the disposition of: N/A
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not Applicable.
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not Applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not Applicable.
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not Applicable.
NOTICE OF DISSOLUTION OF GROUP
ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not Applicable.
CERTIFICATIONS
ITEM 10. CERTIFICATIONS. Not Applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 13, 2024 By: /s/ Vivek Ramaswamy Name: Vivek Ramaswamy